Europe Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Country and Growth Forecast, 2022

List of Tables

The Europe Human Microbiome Market would witness market growth of 31.7% CAGR during the forecast period (2022-2028).

The increased focus on the development of human Microbiome treatment is driving the market growth. Human microbiomes have also established themselves as viable target for therapeutic research. The growing number of market player collaborations is likely to provide a diverse range of growth prospects for market players in the coming years. Moreover, the rising investment by various governments and market players on increasing the research and development activities for bringing developments in the field of human microbiomes.

An aberrant immune reaction to body tissues is induced or triggered by the buildup of disease-causing germs. Autoimmune illnesses, intestinal inflammatory disease, as well as other life-threatening conditions are exacerbated by this. A balanced and systematic interplay develops over time due to the coevolution of the human microbiota and immune system. However, changes in the host-microbiota connection disrupt this interaction, resulting in impaired immune response and perhaps inflammatory disease. A disrupted mucus layer may compromise the intestine's barrier function, resulting in faulty cell linkage attachment. Increased levels of proinflammatory cytokines (IL12, IFN-) and decreased levels of anti-inflammatory cytokines (IL-10) are associated with a reduction in intestinal Firmicutes. In IBD-prone mice, several helminth infections were linked to anti-inflammatory organisms that prevented inflammatory bowel disease.

There is a significant number of regional people that are consuming alcohol. According to the Eurostat, in 2019, 8.4% of EU adults consumed alcohol on a daily basis, 28.8% weekly, 22.8% monthly, while 26.2 % never consumed or had not consumed in the previous 12 months. Alcohol use has been reported to rise with age in the region. People aged 15 to 24 had the lowest proportion of those who consumed alcohol the most frequently (i.e. every day), while those aged 75 and over had the largest share (16.0%). However, the latter age group had the highest percentage (40.3%) of people who had never drunk alcohol or had not consumed any in the previous year.

Weekly alcohol consumption was generally consistent throughout all age groups between 25 and 64, with people aged 45 to 54 having the highest share (33.5%). With age, monthly and less than monthly intake declined little. People aged 25 to 34 had the highest percentage of monthly alcohol consumption (28.5%). Men were more likely than women to use alcohol on a daily and weekly basis (respectively 13.0% of men vs. 4.1% of women and 36.4% of men vs. 21.7% of women). Heavy drinking is defined as consuming more than 60 grams of pure ethanol in a single sitting. Adults in the EU Member States reported heavy drinking episodes at least once a month in proportions ranging from 4% (Cyprus and Italy) to 38% (Denmark).

The Germany market dominated the Europe Human Microbiome Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $72.6 million by 2028. The UK market is poised to grow at a CAGR of 30.6% during (2022 - 2028). Additionally, The France market would display a CAGR of 32.7% during (2022 - 2028).

Based on Product, the market is segmented into Drugs, Diagnostic Tests, Probiotics, Prebiotics, and Others. Based on Disease Type, the market is segmented into Infectious Diseases, Endocrine & Metabolic Disorders, Gastrointestinal Diseases, Cancer, and Others. Based on Technology, the market is segmented into Genomics, Proteomics and Metabolomics. Based on Application, the market is segmented into Therapeutics and Diagnostics. Based on Type, the market is segmented into Microbiome Consortia Transplantation (FMT), Peptide, Live Biotherapeutic Product and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Seres Therapeutics, Inc., 4D pharma plc, OptiBiotix Health Plc, Synlogic, Inc., Second Genome, Inc., Vedanta Biosciences, Inc., Finch Therapeutics Group, Inc., Ferring Holdings SA, and Enterome.

Scope of the Study

Market Segments covered in the Report:

By Product

Drugs
Diagnostic Tests
Probiotics
Prebiotics, and
Others

By Disease Type

Infectious Diseases
Endocrine & Metabolic Disorders
Gastrointestinal Diseases
Cancer, and
Others

By Technology

Genomics
Proteomics
Metabolomics

By Application

Therapeutics
Diagnostics

By Type

Microbiome Consortia Transplantation (FMT)
Peptide
Live Biotherapeutic Product
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Companies Profiled

Seres Therapeutics, Inc.
4D pharma plc
OptiBiotix Health Plc
Synlogic, Inc.
Second Genome, Inc.
Vedanta Biosciences, Inc.
Finch Therapeutics Group, Inc.
Ferring Holdings SA
Enterome

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Europe Human Microbiome Market, by Product
- 1.4.2 Europe Human Microbiome Market, by Disease Type
- 1.4.3 Europe Human Microbiome Market, by Technology
- 1.4.4 Europe Human Microbiome Market, by Application
- 1.4.5 Europe Human Microbiome Market, by Type
- 1.4.6 Europe Human Microbiome Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Europe Human Microbiome Market by Product

3.1 Europe Drugs Market by Country
3.2 Europe Diagnostic Tests Market by Country
3.3 Europe Probiotics Market by Country
3.4 Europe Prebiotics Market by Country
3.5 Europe Others Market by Country

Chapter 4. Europe Human Microbiome Market by Disease Type

4.1 Europe Infectious Diseases Market by Country
4.2 Europe Endocrine & Metabolic Disorders Market by Country
4.3 Europe Gastrointestinal Diseases Market by Country
4.4 Europe Cancer Market by Country
4.5 Europe Others Market by Country

Chapter 5. Europe Human Microbiome Market by Technology

5.1 Europe Genomics Market by Country
5.2 Europe Proteomics Market by Country
5.3 Europe Metabolomics Market by Country

Chapter 6. Europe Human Microbiome Market by Application

6.1 Europe Therapeutics Market by Country
6.2 Europe Diagnostics Market by Country

Chapter 7. Europe Human Microbiome Market by Type

7.1 Europe Microbiome Consortia Transplantation (FMT) Market by Country
7.2 Europe Peptide Market by Country
7.3 Europe Live Biotherapeutic Product Market by Country
7.4 Europe Others Market by Country

Chapter 8. Europe Human Microbiome Market by Country

8.1 Germany Human Microbiome Market
- 8.1.1 Germany Human Microbiome Market by Product
- 8.1.2 Germany Human Microbiome Market by Disease Type
- 8.1.3 Germany Human Microbiome Market by Technology
- 8.1.4 Germany Human Microbiome Market by Application
- 8.1.5 Germany Human Microbiome Market by Type
8.2 UK Human Microbiome Market
- 8.2.1 UK Human Microbiome Market by Product
- 8.2.2 UK Human Microbiome Market by Disease Type
- 8.2.3 UK Human Microbiome Market by Technology
- 8.2.4 UK Human Microbiome Market by Application
- 8.2.5 UK Human Microbiome Market by Type
8.3 France Human Microbiome Market
- 8.3.1 France Human Microbiome Market by Product
- 8.3.2 France Human Microbiome Market by Disease Type
- 8.3.3 France Human Microbiome Market by Technology
- 8.3.4 France Human Microbiome Market by Application
- 8.3.5 France Human Microbiome Market by Type
8.4 Russia Human Microbiome Market
- 8.4.1 Russia Human Microbiome Market by Product
- 8.4.2 Russia Human Microbiome Market by Disease Type
- 8.4.3 Russia Human Microbiome Market by Technology
- 8.4.4 Russia Human Microbiome Market by Application
- 8.4.5 Russia Human Microbiome Market by Type
8.5 Spain Human Microbiome Market
- 8.5.1 Spain Human Microbiome Market by Product
- 8.5.2 Spain Human Microbiome Market by Disease Type
- 8.5.3 Spain Human Microbiome Market by Technology
- 8.5.4 Spain Human Microbiome Market by Application
- 8.5.5 Spain Human Microbiome Market by Type
8.6 Italy Human Microbiome Market
- 8.6.1 Italy Human Microbiome Market by Product
- 8.6.2 Italy Human Microbiome Market by Disease Type
- 8.6.3 Italy Human Microbiome Market by Technology
- 8.6.4 Italy Human Microbiome Market by Application
- 8.6.5 Italy Human Microbiome Market by Type
8.7 Rest of Europe Human Microbiome Market
- 8.7.1 Rest of Europe Human Microbiome Market by Product
- 8.7.2 Rest of Europe Human Microbiome Market by Disease Type
- 8.7.3 Rest of Europe Human Microbiome Market by Technology
- 8.7.4 Rest of Europe Human Microbiome Market by Application
- 8.7.5 Rest of Europe Human Microbiome Market by Type

Chapter 9. Company Profiles

9.1 Ferring Holdings SA
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research and Development Expense
- 9.1.5 Recent Strategies and Developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
- 9.2.1 Company Overview
- 9.2.2 Recent Strategies and Developments:
  - 9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Research & Development Expense
- 9.3.4 Recent Strategies and Developments:
  - 9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Research & Development Expense
- 9.4.4 Recent Strategies and Developments:
  - 9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
- 9.5.1 Company Overview
9.6 Synlogic, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
- 9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
- 9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Research & Development Expense

LIST OF TABLES

TABLE 1 Europe Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 2 Europe Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 3 Europe Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 4 Europe Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 5 Europe Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 6 Europe Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 7 Europe Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 8 Europe Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 9 Europe Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 10 Europe Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 11 Europe Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 12 Europe Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 13 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 14 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 15 Europe Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 16 Europe Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 17 Europe Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 18 Europe Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 19 Europe Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 20 Europe Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 21 Europe Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 22 Europe Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 23 Europe Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 24 Europe Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 25 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 26 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 27 Europe Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 28 Europe Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 29 Europe Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 30 Europe Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 31 Europe Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 32 Europe Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 33 Europe Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 34 Europe Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 35 Europe Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 36 Europe Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 37 Europe Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 38 Europe Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 39 Europe Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 40 Europe Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 41 Europe Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 42 Europe Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 43 Europe Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 44 Europe Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 45 Europe Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 46 Europe Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 47 Europe Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 48 Europe Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 49 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 50 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 51 Europe Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 52 Europe Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 53 Germany Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 54 Germany Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 55 Germany Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 56 Germany Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 57 Germany Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 58 Germany Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 59 Germany Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 60 Germany Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 61 Germany Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 62 Germany Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 63 Germany Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 64 Germany Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 65 UK Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 66 UK Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 67 UK Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 68 UK Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 69 UK Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 70 UK Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 71 UK Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 72 UK Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 73 UK Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 74 UK Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 75 UK Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 76 UK Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 77 France Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 78 France Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 79 France Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 80 France Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 81 France Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 82 France Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 83 France Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 84 France Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 85 France Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 86 France Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 87 France Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 88 France Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 89 Russia Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 90 Russia Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 91 Russia Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 92 Russia Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 93 Russia Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 94 Russia Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 95 Russia Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 96 Russia Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 97 Russia Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 98 Russia Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 99 Russia Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 100 Russia Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 101 Spain Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 102 Spain Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 103 Spain Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 104 Spain Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 105 Spain Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 106 Spain Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 107 Spain Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 108 Spain Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 109 Spain Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 110 Spain Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 111 Spain Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 112 Spain Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 113 Italy Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 114 Italy Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 115 Italy Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 116 Italy Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 117 Italy Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 118 Italy Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 119 Italy Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 120 Italy Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 121 Italy Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 122 Italy Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 123 Italy Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 124 Italy Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 125 Rest of Europe Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 126 Rest of Europe Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 127 Rest of Europe Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 128 Rest of Europe Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 129 Rest of Europe Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 130 Rest of Europe Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 131 Rest of Europe Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 132 Rest of Europe Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 133 Rest of Europe Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 134 Rest of Europe Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 135 Rest of Europe Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 136 Rest of Europe Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 137 key information - Ferring Holdings SA
TABLE 138 Key information - Enterome
TABLE 139 KEY INFORMATION - Seres Therapeutics, Inc.
TABLE 140 Key Information - 4D pharma plc
TABLE 141 key Information - OptiBiotix Health Plc
TABLE 142 Key Information - Synlogic, Inc.
TABLE 143 Key Information - Second Genome, Inc.
TABLE 144 Key Information - Vedanta Biosciences, Inc.
TABLE 145 key information - Finch Therapeutics Group, Inc.

List of Figures

FIG 1 Methodology for the research

Europe Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Country and Growth Forecast, 2022 - 2028

Description

Table of Contents